Atıl Aksoy

Radiation Oncology

[Atıl Aksoy @AtlAksoy]

🎯Proud to share that our article is just published in @CancerControl_

✅ Our study suggests that CT-derived myopenia may be a practical prognostic marker in older patients with prostate cancer receiving radiotherapy.

https://t.co/ofOrzZbHwM

#prostatecancer #radiotherapy

[Atıl Aksoy @AtlAksoy]

🎯Proud to share that my thesis article is published in @TCRT_Cancer

🔑 Our study shows that machine learning models integrating clinical and radiomic features may help predict local recurrence in lung oligometastases treated with SBRT

https://t.co/noX2DLx3M7

#radiomic #sbrt

[Atıl Aksoy @AtlAksoy]

💥 Just published in @Cancers_MDPI .

“Prognostic Impact of Infectious Agents After Definitive Treatment in Non-Small Cell Lung Cancer”

https://t.co/NeGsH0FyHa

Huge thanks to our Radiation Oncology and Microbiology collaborators.

#nsclc #radioherapy #microbiology

[Atıl Aksoy @AtlAksoy]

🚨 A new article from our team!

“Prognostic Value of the CALLY Index in Hypopharyngeal Cancer Treated with Definitive Chemoradiotherapy: A Retrospective Cohort Study”

🔗 https://t.co/0B1fsPeGAQ

Grateful to all collaborators from Dokuz Eylul University and Izmir City Hospital.

[Atıl Aksoy @AtlAksoy]

Bugünkü görevimiz Prostat Kanseri Okulunda. Uygun olanları bekleriz. #prostatkanseri

[Atıl Aksoy @AtlAksoy]

🧠 Is hypercoagulability associated with poor survival in adult glioblastoma?
✅ Our new study says YES.
🧪 D-dimer, PT, and the albumin/D-dimer ratio may help refine prognosis.
📌 Published in Medicina
🔗 https://t.co/C6pMPOupae
#Glioblastoma #Biomarkers #NeuroOncology

[Sean Collins Prostate SBRT @ USF Health @SbrtSean]

Live from UROK 2025

Timur Koca

Radiomics Predicts Progression following RT for High Risk Prostate Cancer

[Dr. Luis A. Pérez-Romasanta @LuisAlberto3P]

Espero que empecéis el año muy robustos,... para cuidar bien de los pacientes frágiles. Y para ello, una lectura recomendada:
Frailty assessment in geriatric radiation oncology https://t.co/Kf04SQ7TIS

[Journal of Geriatric Oncology @JGeriOnc]

The usefulness of the Geriatric-8 screening tool and basic laboratory parameters in older patients with non-small cell lung cancer https://t.co/pcoSH1VdfN @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #RadiationTherapy #Prognosis